Skip to main content
. 2018 Sep 28;20:e00282. doi: 10.1016/j.btre.2018.e00282

Table 5.

Antimicrobial activity of purified compound.

Pathogenic fungi/compound Zone of inhibition (mm)
MIC of compound(mg/mL)
F.moniliforme S.oryzae C.albicans C.tropicalis F.moniliforme S.oryzae C.albicans C.tropicalis
Compound (50 mg) 12.5 ± 0.18 13.8 ± 0.15 11.5 ± 0.15 12.4 ± 0.14 12.5 12.5 6.25 6.25
Compound (100 mg) 14.5 ± 0.22 16.6 ± 0.14 14.8 ± 0.20 15.6 ± 0.22
Amphotericin- B 18.0 18.0
Propiconazole 17.5 17.5